Psychiatry and Neurology, Neurology · Nashville, TN
NPI
1417031535
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 Tvc
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
530 services
Medicare patients, 2024
226
Average age 64
Drug cost, 2024
$6.4M
3,132 prescriptions
Company payments, 2025
$22K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harold Moses was code 99214 (office e&m - established), 266 times for 189 patients. In total Harold Moses billed 530 services in 7 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 266 | 189 | $58.15 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 111 | 106 | $12.48 | $1,386 |
| 99215 Office E&M - Established | Office | 40 | 37 | $72.06 | $2,882 |
| 99213 Office E&M - Established | Office | 27 | 22 | $57.11 | $1,542 |
By year: 2022 $23K for 420 services; 2023 $22K for 383 services; 2024 $22K for 530 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harold Moses prescribed most often to Medicare patients was Gabapentin, with 395 prescriptions and refills. In total Harold Moses wrote 3,132 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 395 | 639 | 91 | $8,207 |
| Baclofen Generic | 387 | 712 | 94 | $9,136 |
| Dimethyl Fumarate Generic | 147 | 155 | 16 | $86K |
| Tizanidine Hcl Generic | 126 | 262 | 37 | $2,322 |
| Dalfampridine Er Dalfampridine | 123 | 246 | 28 | $101K |
| Carbamazepine Generic | 115 | 220 | 29 | $5,940 |
| Kesimpta Pen Ofatumumab | 107 | 107 | Under 11 | $884K |
| Copaxone Glatiramer Acetate | 93 | 93 | Under 11 | $520K |
| Diazepam Generic | 76 | 76 | 21 | $380 |
| Modafinil Generic | 61 | 75 | 14 | $2,518 |
| Amantadine Amantadine Hcl | 59 | 126 | 15 | $2,423 |
| Tecfidera Dimethyl Fumarate | 57 | 65 | Under 11 | $582K |
| Fingolimod Fingolimod Hcl | 52 | 60 | Under 11 | $147K |
| Oxcarbazepine Generic | 51 | 105 | Under 11 | $2,779 |
| Duloxetine Hcl Generic | 51 | 111 | 12 | $1,451 |
Brand drugs: 518 claims; generic drugs: 2,614 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harold Moses $22K ($22K in general payments such as food, travel and fees) from 6 companies. The largest payer was Genentech USA, Inc. with $7,851.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.